Royal Philips joins the list of companies taking advantage of the relaxed FDA guidelines with its plans to launch its prenatal monitoring platforms in the U.S.
The Fetal and Maternal Pod and Patch will be able to continuously monitor both the maternal heart rate and fetal heart rate, as well as uterine activity, with a dispensable electrode patch. The tech is intended for high-risk pregnancies....
